Roger E. Girard
Fundador en Varidi, Inc. .
Perfil
Mr. Roger E.
Girard is Chief Strategy Officer at Acucela, Inc. and a Managing Director & Board Member at Xecutive Advisory Partners LLC.
Mr. Girard was previously employed as Chairman by Biomoles, Inc., a Principal by ArtVentive Medical Group, Inc., Chairman, President & Chief Executive Officer by IsoRay, Inc., President by Strategic Financial Services, Inc., Chairman, President & Chief Executive Officer by IsoRay Medical, Inc., and Managing Partner-Northwest Office by Capital Consortium.
He received his undergraduate degree from the University of Washington.
Cargos activos de Roger E. Girard
| Empresas | Cargo | Inicio |
|---|---|---|
Xecutive Advisory Partners LLC
 Xecutive Advisory Partners LLC Investment ManagersFinance Founded in 2008 by Jim Torina, Pat Murphy and Len Jessup, Xecutive Advisory Partners LLC, formerly the University Funds LLC, is a venture capital firm located in Bellevue, Washington. | Inversor de Capital Privado | 07/03/2012 |
Varidi, Inc.
 Varidi, Inc. Internet Software/ServicesTechnology Services Varidi, Inc. provides a cloud-based payment platform for businesses to offer merchant provided financing to their customers. The firm focuses on providing solutions for healthcare providers. Its platform provides custom-fit payment options to the healthcare, car repairs, pet care, and home repair sectors. The company was founded by Roger E. Girard and Dwight Jackson in 2013 and is headquartered in Woodinville, WA. | Fundador | 01/01/2013 |
Antiguos cargos conocidos de Roger E. Girard.
| Empresas | Cargo | Fin |
|---|---|---|
| ACUCELA INC | Corporate Officer/Principal | 10/07/2016 |
| ARTVENTIVE MEDICAL GROUP INC | Corporate Officer/Principal | 30/04/2011 |
| Biomoles, Inc. | Presidente | 28/02/2011 |
| IsoRay Medical, Inc. /Old/ | Presidente | - |
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Presidente | 26/02/2008 |
Formación de Roger E. Girard.
| University of Washington | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Empresas privadas | 10 |
|---|---|
| Strategic Financial Services, Inc. | Finance |
| IsoRay Medical, Inc. /Old/ | Health Technology |
| Biomoles, Inc. | |
Varidi, Inc.
Varidi, Inc. Internet Software/ServicesTechnology Services Varidi, Inc. provides a cloud-based payment platform for businesses to offer merchant provided financing to their customers. The firm focuses on providing solutions for healthcare providers. Its platform provides custom-fit payment options to the healthcare, car repairs, pet care, and home repair sectors. The company was founded by Roger E. Girard and Dwight Jackson in 2013 and is headquartered in Woodinville, WA. | Technology Services |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
| Capital Consortium | |
ArtVentive Medical Group, Inc.
 ArtVentive Medical Group, Inc. Medical SpecialtiesHealth Technology ArtVentive Medical Group, Inc. engages in the provision of developing, manufacturing, and marketing a family of endoluminal occlusion devices. The company was founded by Rudakov Leon on January 23, 2007 and is headquartered in San Marcos, CA. | Health Technology |
Xecutive Advisory Partners LLC
Xecutive Advisory Partners LLC Investment ManagersFinance Founded in 2008 by Jim Torina, Pat Murphy and Len Jessup, Xecutive Advisory Partners LLC, formerly the University Funds LLC, is a venture capital firm located in Bellevue, Washington. | Finance |
Neuro-ID, Inc.
 Neuro-ID, Inc. Packaged SoftwareTechnology Services Neuro-ID, Inc. develops and provides prescriptive analytics solutions for the risk industry. The firm offers solutions that measure and analyze how people respond to questions in real time. It provides Neuro-CS, a real-time analytics solution focusing on applicant behavior patterns. The company was founded by Jeff Jenkins and Joseph Valacich in 2014 and is headquartered in Whitefish, MT. | Technology Services |
- Bolsa de valores
- Insiders
- Roger E. Girard